Patent Assignment
Reel/Frame 060678/0858
Change of Name
Recorded: 2022-07-15
Pages: 3
Assignor
IMPEL NEUROPHARMA, INC.
Executed: 2022-04-15
Assignee
IMPEL PHARMACEUTICALS INC.
201 ELLIOTT AVENUE WEST, SUITE 260, SEATTLE, WASHINGTON, 98119
Covered Property
(1)
In-line Nasal Delivery Device
Application:
17/866,222 →
Publication:
US 2023/0095719
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.